Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug spending in Canada: recent trends and causes.

Steve Morgan1

  • 1Department of Health Care and Epidemiology, University of British Columbia, Vancouver, Canada. morgan@chspr.ubc.ca

Medical Care
|June 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing enhanced extracorporeal membrane oxygenation for CPR (ECPR) in the emergency department.

International journal of emergency medicine·2024
Same author

Inappropriate use of clinical practices in Canada: a systematic review.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2022
Same author

Accurate neonatal heart rate monitoring using a new wireless, cap mounted device.

Acta paediatrica (Oslo, Norway : 1992)·2020
Same author

Inappropriateness of health care in Canada: a systematic review protocol.

Systematic reviews·2019
Same author

Mucosal injury following short-term tracheal intubation: A novel animal model and composite tracheal injury score.

Laryngoscope investigative otolaryngology·2018
Same author

Is cardiovascular risk reduction therapy effective in South Asian, Chinese and other patients with diabetes? A population-based cohort study from Canada.

BMJ open·2017
Same journal

Hepatitis C Virus Cascade of Care in Florida Emergency Departments.

Medical care·2026
Same journal

Association of Neighborhood Socioeconomic Disadvantage and Uptake of Diabetes Prevention Interventions.

Medical care·2026
Same journal

Machine Learning for Evaluating the Heterogeneous Effects of Intensive In-Hospital Rehabilitation During the Postacute Phase After Hip Fracture Surgery on Activities of Daily Living.

Medical care·2026
Same journal

Hospital-Physician Integration and Differences in the Use of Orthopedic Care Across Race and Ethnicity.

Medical care·2026
Same journal

Temporal Misalignment and Selection Bias in "Burn Pit Smoke Exposure and Sleep Apnea in US Veterans.

Medical care·2026
Same journal

The Impact of an Oncology Hospital at Home Program on Health Care Costs.

Medical care·2026
See all related articles

Canadian prescription drug spending increased significantly from 1998-2002, driven by higher drug use and changing therapeutic choices, not price increases. Cost-management strategies should address utilization and choices.

Area of Science:

  • Health Economics
  • Pharmaceutical Policy
  • Public Health

Background:

  • Canadians spent nearly $15 billion on prescription drugs in 2002, averaging over $460 per capita.
  • Limited published evidence exists on the drivers of these substantial prescription drug expenditures.
  • This study addresses the lack of data on the nature and causes of drug spending in Canada.

Purpose of the Study:

  • To analyze the nature and determinants of prescription drug expenditures in Canada.
  • To investigate the period of rapid expenditure inflation from 1998 to 2002.
  • To identify key factors influencing rising drug costs.

Main Methods:

  • Utilized nonstochastic index-theoretical methods to decompose expenditure trends.
  • Analyzed overall expenditures and investment in specific therapeutic categories.

Related Experiment Videos

  • Attributed changes in per capita spending on oral solid prescription drugs to six determinants across volume, price, and therapeutic choices.

    • Main Results:

    • Spending was concentrated in five main therapeutic classes.
    • Drug prices, adjusted for generic use, decreased during the study period.
    • Increased prescription drug utilization accounted for over half of the per capita spending growth; therapeutic choices also contributed to rising costs.

    Conclusions:

    • Federal price regulations, provincial price freezes, and generic substitution policies effectively controlled price-related drug spending.
    • Increased drug utilization and shifts in therapeutic choices present challenges for cost-management strategies.
    • Future cost-management must consider factors beyond price, including utilization and prescribing patterns.